Oral Therapy using Anti-Oxidants for Alzheimer's Disease

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$100,816.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43AG023456-01A1
Agency Tracking Number:
AG023456
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
NANOTHERAPEUTICS, INC.
NANOTHERAPEUTICS, INC., 12085 RESEARCH DR, STE N, ALACHUA, FL, 32615
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
BARBEL Eppler
(386) 462-9663
JTALTON@NANOTHERAPEUTICS.COM
Business Contact:
JAMES TALTON
(386) 462-9663
JTALTON@NANOTHERAPEUTICS.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Nanotherapeutics proposes to evaluate oral taurine therapy for Alzheimer's disease (AD). AD, the most common form of dementia among older people, affects over 4 million Americans. It requires full-time care in the

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government